Efficacy of Everolimus Combined with <sup>177</sup>Lu-Dotatate in the Treatment of Neuroendocrine Tumors.

导出 LinkOut

翻译打印收藏纠错

第一作者： Ali,Aljubran

第一单位： Department of Medical Oncology, Oncology Center, King Faisal Specialist Hospital and Research Centre, Riyadh, Saudi Arabia.

作者： Ali,Aljubran ^[1] ; Ahmed,Badran ^[1] ; Mohamed,Alrowaily ^[2] ; Hussein,Raef ^[3] ; Ahmed M,Alzahrani ^[4] ; Ahmed,Almuhaideb ^[1] ; Hadeel,Almanea ^[3] ; Abdelmoneim,El-Dali ^[5] ; Mahmoud,Tuli ^[6] ; Shouki,Bazarbashi ^[3]

作者单位： Department of Medical Oncology, Oncology Center, King Faisal Specialist Hospital and Research Centre, Riyadh, Saudi Arabia. ^[1] Department of Clinical Oncology and Nuclear Medicine, Ain Shams University, Cairo Egypt. ^[2] Department of Radiology, King Faisal Specialist Hospital and Research Centre, Riyadh, Saudi Arabia. ^[3] Section of Endocrinology, Department of Medicine, King Faisal Specialist Hospital and Research Centre, Riyadh, Saudi Arabia. ^[4] Department of Pathology, King Faisal Specialist Hospital and Research Centre, Riyadh, Saudi Arabia. ^[5] Department of Biostatistics, Epidemiology and Scientific Computing, King Faisal Specialist Hospital and Research Centre, Riyadh, Saudi Arabia. ^[6]

关键词 everolimus lutetium Dotatate neuroendocrine tumors peptide receptor radionuclide therapy